DOSE DEPENDENCE OF THE CYTOKINETIC AND CYTOTOXIC EFFECTS OF EPIRUBICIN INVITRO

被引:14
作者
BARTKOWIAK, D [1 ]
HEMMER, J [1 ]
ROTTINGER, E [1 ]
机构
[1] UNIV ULM,DEPT ORAL & MAXILLOFACIAL SURG,W-7900 ULM,GERMANY
关键词
D O I
10.1007/BF00686310
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
CHO cells were exposed in vitro for 1 h to concentrations of 0.1-20-mu-g/ml of the cytostatic drug epirubicin. Population growth, survival fractions, cell-cycle-phase distribution, and BrdU incorporation were analyzed. A fraction of the cells showed a transitory cytostatic reaction at 1-mu-g/ml, and >99% of the cells were killed at 10-mu-g/ml. The survival curve was biphasic with a steep slope at concentrations of up to 5-mu-g/ml. Approximately 0.1% of the cells were resistant to higher concentrations of epirubicin. Bivariate DNA/BrdU flow cytometry revealed that the sensitive cells were blocked and probably killed in the G2M phase of the cell cycle.
引用
收藏
页码:189 / 192
页数:4
相关论文
共 20 条
[1]  
ALTAVILLA G, 1989, TUMORI, V51, P168
[2]  
BARANCO SC, 1986, CELL CYCLE EFFECT DR, P251
[3]  
BARANCO SC, 1975, CANCER CHEMOTH REP, V6, P147
[4]   MECHANISM OF MULTIDRUG RESISTANCE [J].
BRADLEY, G ;
JURANKA, PF ;
LING, V .
BIOCHIMICA ET BIOPHYSICA ACTA, 1988, 948 (01) :87-128
[5]  
BRAUNSCHWEIGER PG, 1980, CANCER TREAT REP, V64, P3812
[6]   CELLULAR AND MOLECULAR PHARMACOLOGY OF 4'-EPIDOXORUBICIN IN HELA-CELLS - COMPARISON WITH ITS PARENT DRUG, DOXORUBICIN [J].
CANTONI, O ;
SESTILI, P ;
CATTABENI, F ;
GERONI, C ;
GRANDI, M ;
GIULIANI, FC .
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 1989, 115 (04) :373-378
[7]   COMPARATIVE EFFECTS OF DOXORUBICIN AND 4'-EPIDOXORUBICIN ON NUCLEIC-ACID METABOLISM AND CYTOTOXICITY IN A HUMAN TUMOR-CELL LINE [J].
CANTONI, O ;
SESTILI, P ;
CATTABENI, F ;
GERONI, C ;
GIULIANI, F .
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1990, 27 (01) :47-51
[8]   WEEKLY ADRIAMYCIN VS 4-EPIDOXORUBICIN EVERY 2ND WEEK IN ADVANCED BREAST-CANCER - A RANDOMIZED TRIAL [J].
GUNDERSEN, S ;
KVINNSLAND, S ;
KLEPP, O ;
LUND, E ;
HOST, H .
EUROPEAN JOURNAL OF CANCER, 1990, 26 (01) :45-48
[9]  
HEIDEMANN E, 1990, ONKOLOGIE, V13, P24
[10]   RAPID INVITRO BROMODEOXYURIDINE LABELING METHOD FOR MONITORING OF THERAPY RESPONSE IN SOLID HUMAN TUMORS [J].
HEMMER, J .
CYTOMETRY, 1990, 11 (05) :603-609